Tag: David Epstein

November 24, 2015 Off

Novartis’ heart failure tablet Entresto available in EU

European Commission has approved Switzerland-based Novartis’ Entresto tablets for treating adult patients with symptomatic chronic heart failure with reduced ejection fraction.

November 23, 2015 Off

Green light in EU for Novartis’ Cosentyx

By Dino Mustafić

The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS.